Biblio
Export 215 results:
[ Author
Filters: First Letter Of Last Name is M [Clear All Filters]
“Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.”, J Alzheimers Dis, vol. 62, no. 3, pp. 965-992, 2018.
, “Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.”, J Alzheimers Dis, vol. 74, no. 1, pp. 391-405, 2020.
, “Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S365-S378, 2018.
, “A Prototype for the Voice Analysis Diagnosis of Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 2, pp. 473-481, 2018.
, “Assessing Mild Cognitive Impairment Progression using a Spherical Brain Mapping of Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 65, no. 3, pp. 713-729, 2018.
, “Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 2, pp. 525-540, 2019.
, “Cognitive Impairment Is a Common Comorbidity in Deceased COVID-19 Patients: A Hospital-Based Retrospective Cohort Study.”, J Alzheimers Dis, vol. 78, no. 4, pp. 1367-1372, 2020.
, “Early Cognitive Deficits in Type 2 Diabetes: A Population-Based Study.”, J Alzheimers Dis, vol. 53, no. 3, pp. 1069-78, 2016.
, “Evaluating Peripersonal Space through the Functional Transcranial Doppler: Are We Paving the Way for Early Detecting Mild Cognitive Impairment to Dementia Conversion?”, J Alzheimers Dis, vol. 62, no. 1, pp. 133-143, 2018.
, “Usefulness of an Integrated Analysis of Different Memory Tasks to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease: The Episodic Memory Score (EMS).”, J Alzheimers Dis, vol. 50, no. 1, pp. 61-70, 2016.
, “Comparison of Model-Based Indices of Cerebral Autoregulation and Vasomotor Reactivity Using Transcranial Doppler versus Near-Infrared Spectroscopy in Patients with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 56, no. 1, pp. 89-105, 2017.
, “Subjective Cognitive Complaints in Cognitively Healthy Older Adults and Their Relationship to Cognitive Performance and Depressive Symptoms.”, J Alzheimers Dis, vol. 59, no. 3, pp. 871-881, 2017.
, “Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
, “Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 683-697, 2020.
, “Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.”, J Alzheimers Dis, 2018.
, “Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 275-283, 2017.
, “Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 73-8, 2016.
, “Care Plan Improvement in Nursing Homes: An Integrative Review.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1621-1638, 2017.
, “The Impact of a Shared Decision-Making Training Program on Dementia Care Planning in Long-Term Care.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1123-1135, 2018.
, “Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis.”, J Alzheimers Dis, vol. 63, no. 1, pp. 227-238, 2018.
, “Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1123-1133, 2016.
, “PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.”, J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.
, “Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases.”, J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
, “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
, “microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 113-123, 2018.
,